Branch Retinal Vein Occlusion (BRVO)

Anti-VEGF injections are our first-line treatment for BRVO-related macular edema and often significantly improve vision. These medications block proteins that cause blood vessel leakage and abnormal growth. We use FDA-approved agents such as aflibercept and ranibizumab; bevacizumab is an effective off-label option used widely in practice. Faricimab is a newer FDA-approved agent that may be used in select cases. Most patients need a series of monthly injections initially, with the frequency adjusted based on your response to treatment.

Steroid injections are generally reserved for patients who do not respond well to anti-VEGF therapy or have significant inflammation. These powerful anti-inflammatory medications like dexamethasone implant or triamcinolone can reduce swelling effectively, though we carefully monitor for potential side effects like elevated eye pressure or cataract formation.

Focal or grid laser treatment may be used for persistent macular swelling that does not respond to injections when blood flow is adequate. For areas with poor blood flow and abnormal vessel growth, scatter laser treatment can reduce the risk of bleeding and other serious complications by treating the affected retinal tissue. We generally avoid preventive laser before new vessel growth if we can monitor you closely.

Our skilled vitreoretinal surgeons may recommend pars plana vitrectomy for cases involving non-clearing blood in the vitreous, retinal pulling, or other complex issues. During surgery, we may use endolaser treatment to address areas of poor blood flow. These surgical decisions are carefully individualized based on your eye's anatomy, visual goals, and overall health status.

We work closely with your primary care doctor, cardiologist, endocrinologist, and other specialists to optimize your blood pressure, cholesterol, and blood sugar control. This coordinated approach is crucial for protecting your vision and reducing the risk of future vascular problems in both eyes. In younger patients or those with recurrent problems, we may discuss evaluation for genetic blood clotting disorders such as factor V Leiden or prothrombin gene mutations, though blood thinners are not typically used to treat the eye blockage itself.

Yes, BRVO can cause permanent vision loss, especially when there is poor blood flow to the retina or untreated macular swelling. However, timely treatment with anti-VEGF injections and appropriate additional therapies significantly reduce this risk and frequently stabilize or improve vision. Early evaluation and treatment improve the likelihood of regaining or maintaining functional sight.

BRVO typically affects only one eye, but having BRVO does slightly increase your risk of developing it in the other eye. This is why controlling systemic risk factors and continuing routine comprehensive eye exams remain important for protecting both eyes. Regular dilated exams help catch changes early if they do occur.

BRVO is sometimes called an eye stroke because it involves a blockage in retinal blood flow, similar to a stroke in the brain. However, the evaluation, treatment, and health implications are different. BRVO is associated with a slightly higher risk of systemic stroke and heart events, particularly in the first year. We coordinate with your physicians to optimize blood pressure, lipids, diabetes, and screen for sleep apnea.

Treatment duration varies significantly between patients. Some people need only a short series of injections over a few months, while others require extended treatment courses or maintenance therapy. Your treatment plan is guided by OCT findings showing macular swelling and your vision response over time. Follow-up intervals are gradually lengthened once your eye is stable.

With proper numbing drops and our gentle injection technique, most patients feel brief pressure rather than pain during the injection. The procedure takes only a few seconds to complete, and most people are surprised by how comfortable it is with minimal downtime afterward. Mild irritation is common for a day, but severe pain or vision loss is not expected and should be reported promptly.

Temporary vision blurring after pupil dilation or injection is common and expected. We recommend arranging transportation for your initial visits until you know how your eyes respond to treatment. Many patients comfortably return to normal activities the same day, and you can resume driving when your vision clears and you feel comfortable behind the wheel.

We work with your other doctors to optimize medications that affect blood pressure, cholesterol, and blood clotting. Sometimes adjustments are beneficial for your eye health, but we coordinate these decisions with your primary care physician and specialists to ensure your overall health needs are met.

The best prevention involves controlling blood pressure and cholesterol levels, managing diabetes carefully if present, avoiding smoking, maintaining a healthy weight, and continuing regular dilated eye exams. These steps help detect changes early and reduce your risk of additional retinal vascular problems. Home monitoring with an Amsler grid and reporting new symptoms can help ensure timely care.

Contact our office immediately if you experience sudden vision changes, new floaters, flashing lights, or a curtain-like shadow in your vision. These symptoms may indicate new complications that require prompt evaluation and treatment to protect your vision.

In younger patients or those with recurrent or bilateral BRVO, genetic conditions like factor V Leiden or prothrombin gene mutations may be present. We may recommend blood tests to check for these conditions, especially if you have a family history of blood clots or other risk factors. Treatment focuses on managing the eye condition and coordinating with your other doctors for overall health care.

Anti-VEGF and steroid treatments are generally less effective in cases with poor blood flow to the central retina compared to cases with adequate blood flow. However, treatment can still be beneficial for reducing swelling and preventing complications. Your doctor will discuss realistic expectations based on your specific type of BRVO.

The original blockage typically does not resolve completely, but the swelling and vision problems can be well-controlled with treatment. Some patients experience return of swelling months or years later, and it typically responds when treatment is resumed.